1 / 95

Blood Transfusion Dr Emer Lawlor, IBTS 3rd February 2003

Blood Transfusion Dr Emer Lawlor, IBTS 3rd February 2003. First Blood Transfusions. Harvey Discovered Circulation of Blood. 1628. Wilkins & Lower Transfusions from dog to dog. 1665-’66. 1667. Jean-Baptiste Denis Performed first recorded blood transfusions from animals to humans.

adanne
Download Presentation

Blood Transfusion Dr Emer Lawlor, IBTS 3rd February 2003

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Blood TransfusionDr Emer Lawlor, IBTS3rd February 2003

  2. First Blood Transfusions Harvey Discovered Circulation of Blood 1628 Wilkins & Lower Transfusions from dog to dog 1665-’66 1667 Jean-Baptiste Denis Performed first recorded blood transfusions from animals to humans

  3. 19th Century Transfusions 1818 James Blundell, Obstetrician First transfusion of human to human

  4. Early transfusion: Paris, France

  5. 20th Century Transfusions 1901 Karl Landsteiner Discovers A, B, O Blood Groups

  6. 20th Century Transfusions 1902 AB Group discovered Importance of crossmatching blood between donor & recipient 1907 Sodium Citrate proposed as anticoagulant 1914 1936 First Blood Bank: Barcelona, Spanish Civil War Levine & Landsteiner, Rhesus blood Group System 1940

  7. Bad Blood France, Switzerland, Italy, Netherlands, Germany, Denmark, Ireland, Australia, New Zealand, Canada, USA Japan

  8. Aims of Transfusion Centre • Provision of Blood of the best possible quality and safety for the patient receiving it • To care for the donor - ensure act of donation does not harm donor

  9. Blood Supply Chain • Blood Donor Screening Criteria • Donation Process • Donation Testing • Component preparation • Plasma Products

  10. Donor Screening • Self deferral of ‘At Risk’ groups • Health Questionnaire • Microbiological screening of each donation

  11. Blood Donor Criteria • Age 17-65 ( new donors until 60) • Weight > 50kg ( 7st 12Ibs) • General health • Specific illnesses • Contact with infection

  12. Blood Donor Criteria • HIV,Hepatitis risk • Medication • CJD • Hb > 13 M; >12 F

  13. Haemoglobin Testing

  14. Alternatives to Voluntary Donors: Autologous • 5-10% of patients are fit to predeposit autologous blood • Orthopaedic, Plastic Surgery, Gynaecology • Up to 5 units can be predeposited/1 week • Increased donor reactions • Still have risk of : Clerical error, Bacterial Infections

  15. Alternatives to Voluntary Donors: Directed • Relatives or friends • Not demonstrably safer • Not voluntary • Viral marker rates higher as often first time donors • TA-GVHD

  16. Blood Donation • 475mls Blood + 63mls anticoagulant Red Cells Plasma Buffy Coat Platelets • Red Cells + Optimal Additive Solution Saline Adenine SAGM Glucose Mannitol • Expiry date 35 days

  17. Blood Components and Products

  18. Blood Component Production

  19. Blood Component Production

  20. Leucodepletion • Universal leucodepletion introduced in 1999 to reduce the risk of vCJD transmission by blood • other benefits - less febrile reactions, less alloimmunisation, less GVHD, ? reduce immunosuppresssive effects

  21. Leucodepletion

  22. Platelets • Pools prepared from buffycoats of whole blood donations (4 donations)- • Apheresis concentrates from one donor using a cell separator • pool/apheresis pack (250mls) = standard adult dose

  23. Blood Donation Testing • Microbiology markers • Blood grouping and screening for high titre antibodies • Quality monitoring

  24. A O B

  25. ABO Groups

  26. Frequency of ABO & Rh(D) Groups in Ireland • Group O 56% • Group A 31% • Group B 11% • Group AB 2.5% • Rh (D) positive 85% • Rh (D) negative 15%

  27. ABO Grouping Patient Red Cells Test Reagents

  28. Cells v Serum Serum v Cells

  29. Current anti HIV 1+2 HIV PCR HBsag HBc assay anti HCV HCV PCR anti HTLV1/2 syphilis anti CMV Future Bacterial culture of components Prions Microbiology testing

  30. Hospital Blood Transfusion Laboratory Patient/donor testing and product selection and issue

  31. Tests prior to transfusion Hospital IBTS • ABO & Rh typing • Antibody screen Patient Donor Donor • ABO & Rh typing • Antibody screen Compatibility Test (x-match) Donor red cells + patients serum Saline and LISS Coombs

  32. Antigens on Red Cells

  33. Blood Group Antibodies 1. Naturally occurring: - ABO - Anti-Hi, P1, E Immune 2. Pregnancy: - Rhesus, Kell, Fya + Others 3. Transfusion: - Rh, Kell, Fy, JKa + Others

  34. Conventional Testing. Weak reactions often difficult to interpret. Can also be downgraded due to shaking the completed test.

  35. Principle of Gel Technology • The sephadex gel matrix acts as a sieve. • Large agglutinates remain on or near the top of the gel interface. • Smaller agglutinates pass partway through the gel, depending on size. • Unagglutinated cells pass to the base of the microtube

  36. ABO/Rh Typing Group B RhD positive

  37. Antibody Screening Positive antibody screen. Antibody could cause a transfusion reaction or affect an unborn baby.

  38. Purpose of Crossmatch • Detect unsuspected ABO incompatibility Donor centre Error in laboratory • Detection of unsuspected antibodies in <1% cases

  39. Crossmatching Crossmatch ABO Group Donor and patient compatible. Unit safe to transfuse. Patient B Positive Recipient Serum Donor Red Cells

  40. Electronic Crossmatch • Donor units • Repeat ABO Rh groups performed on all donor units • Automated Grouping • Validated computer software to ensure that ABO incompatible units cannot be selected for patient

  41. Blood Component Storage • Whole blood/red cells - 2-6C for up to 35 days use within 5 hours of removal from blood fridge • Platelets -20-24C on agitator for 5 days • SD Fresh frozen plasma ( FFP) for 6 months - use within 4 hrs of thawing • Cryoprecipitate -30C use within 4 hours of thawing

  42. Haemovigilance Looping the Loop Safety of the Transfusion Chain from Vein to Vein Right Blood Right Patient Right Time = + + 

  43. Transfusion Chain • Supply from Transfusion Centre • Patient and sample identification • Transport of sample to laboratory • Laboratory ordering/testing process • Storage • Delivery of blood unit to patient • Administration • Monitoring • Adverse Reaction reporting • Guidelines,Audit and Review (outside loop)

  44. Transfusion Chain • Hospital • patient & sample • Identification • Haemovigilance • Adverse Reaction • reporting • Guidelines, Audit • & review • Transfusion • Centre • Blood Supplied • Laboratory • Ordering • Testing • Storage • Patient • Blood Administered • Monitored

  45. NHO Incidents (category) 1999-2001

  46. Transfusion Chain • Supply from Transfusion Centre • Patient and sample identification • Transport of sample to laboratory • Laboratory ordering/testing process • Storage • Delivery of blood unit to patient • Administration • Monitoring • Adverse Reaction reporting • Guidelines,Audit and Review

  47. IBCT (n=31) ‘Site of First Error’

  48. Wrong Pre-Transfusion Samples • 2 cases in the first two years of NHO reporting • NHO audit 2000: 40% samples not labelled at bedside as per guidelines or prelabelled • Untoward incident reports St Elsewhere’s 2000 • 8 wrong patient samples bled • samples out of hours • non phlebotomy staff • prelabelled tubes • musical beds Near Misses only because lab had historic group on patient!

  49. Wrong ABO Group - Case 1 • Pre transfusion sample was taken from wrong patient. • Patient received an ABO incompatible transfusion. • Transfusion reaction investigations led to the identification of multiple errors. NHO Report, 2001

More Related